Immuneering Corporation Other Non-Current Liabilities
Immuneering Corporation (IMRX) had Other Non-Current Liabilities of $9.90 thousand as of 2022-06-30, per its 10-Q filed 2022-08-10.
Discontinued › Balance Sheet
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-08-10
- 2022-06-30: Other Liabilities, Noncurrent $9.90K.
- 2022-03-31: Other Liabilities, Noncurrent $9.90K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2022-06-30 | $9.90K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $9.90K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |